Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

BActinium-1: A Phase 1b, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Intravenous Administration of B7-H3 Radiopharmaceutical ([225Ac]Ac-AKY-2519) in Metastatic Castration-Resistant Prostate Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07581184
Title field or adapter rule
{'original_value': 'BActinium-1: A Phase 1b, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Intravenous Administration of B7-H3 Radiopharmaceutical ([225Ac]Ac-AKY-2519) in Metastatic Castration-Resistant Prostate Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:28.467368+00:00
Published At
2026-10-30T00:00:00+00:00
Record Updated At
2026-10-30
Source Retrieved At
2026-10-31T22:18:05.512861+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Castration Resistant Metastatic Prostate Cancer", "Prostate Cancer", "mCRPC (Metastatic Castration-resistant Prostate Cancer)", "mCRPC", "B7H3"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-30", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07581184"
protocolSection.identificationModule.officialTitle
"BActinium-1: A Phase 1b, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Intravenous Administration of B7-H3 Radiopharmaceutical ([225Ac]Ac-AKY-2519) in Metastatic Castration-Resistant Prostate Cancer"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Castration Resistant Metastatic Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • mCRPC (Metastatic Castration-resistant Prostate Cancer) (protocolSection.conditionsModule.conditions)
  • mCRPC (protocolSection.conditionsModule.conditions)
  • B7H3 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['[225Ac]Ac-AKY-2519'], 'description': '\\[225Ac\\]Ac-AKY-2519 Injection', 'name': '[225Ac]Ac-AKY-2519 (therapeutic)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['[225Ac]Ac-AKY-2519'], 'description': '\\[64Cu\\]Cu-AKY-2519 Injection', 'name': '[64Cu]Cu-AKY-2519 (imaging)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • [225Ac]Ac-AKY-2519 (therapeutic) (protocolSection.armsInterventionsModule.interventions[].name)
  • [64Cu]Cu-AKY-2519 (imaging) (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.